全文获取类型
收费全文 | 1079篇 |
免费 | 58篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 32篇 |
妇产科学 | 7篇 |
基础医学 | 87篇 |
口腔科学 | 13篇 |
临床医学 | 56篇 |
内科学 | 331篇 |
皮肤病学 | 17篇 |
神经病学 | 31篇 |
特种医学 | 41篇 |
外科学 | 260篇 |
综合类 | 1篇 |
预防医学 | 4篇 |
眼科学 | 6篇 |
药学 | 57篇 |
中国医学 | 3篇 |
肿瘤学 | 154篇 |
出版年
2024年 | 1篇 |
2023年 | 10篇 |
2022年 | 20篇 |
2021年 | 43篇 |
2020年 | 30篇 |
2019年 | 30篇 |
2018年 | 25篇 |
2017年 | 33篇 |
2016年 | 28篇 |
2015年 | 41篇 |
2014年 | 50篇 |
2013年 | 46篇 |
2012年 | 77篇 |
2011年 | 110篇 |
2010年 | 46篇 |
2009年 | 51篇 |
2008年 | 88篇 |
2007年 | 65篇 |
2006年 | 54篇 |
2005年 | 39篇 |
2004年 | 34篇 |
2003年 | 47篇 |
2002年 | 49篇 |
2001年 | 9篇 |
2000年 | 7篇 |
1999年 | 7篇 |
1998年 | 19篇 |
1997年 | 9篇 |
1996年 | 6篇 |
1995年 | 14篇 |
1994年 | 9篇 |
1993年 | 5篇 |
1992年 | 5篇 |
1991年 | 5篇 |
1990年 | 3篇 |
1989年 | 1篇 |
1988年 | 4篇 |
1987年 | 4篇 |
1986年 | 2篇 |
1985年 | 5篇 |
1984年 | 1篇 |
1983年 | 3篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1977年 | 1篇 |
1973年 | 2篇 |
1972年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有1145条查询结果,搜索用时 15 毫秒
31.
Teru Kamogashira Yusuke Akamatsu Akinori Kashio Erika Ogata Shotaro Karino Akinobu Kakigi 《Acta oto-laryngologica》2016,136(1):78-82
Conclusions: CI improves hearing thresholds and auditory skills in children with most types of inner ear malformations. However, the development of sound detection skills is not as good as it is in children without inner ear malformations. Objectives: To investigate the influence of inner ear malformations on development of auditory skills after cochlear implantation (CI). Methods: Records of 20 children with inner ear malformations who underwent cochlear implantation before 4 years of age and followed up for more than 2 years were retrospectively reviewed. Hearing thresholds, the Meaningful Auditory Integration Scale (MAIS), and Meaningful Use of Speech Scale (MUSS) scores before and after CI were analyzed and compared with 20 age-matched deaf children who underwent CI. Results: The children with inner ear malformations showed significant improvements in hearing thresholds and the MAIS and MUSS scores 1 year after CI (p?0.01). However, their development of the MAIS scores was significantly delayed compared to children without inner ear malformations (p?0.05), while there was no significant difference in development of the MUSS scores between them. Significant improvements in hearing thresholds and the MAIS and MUSS scores were observed in cochlear hypoplasia and incomplete partition (p?0.05). 相似文献
32.
Ohira Masafumi Yoshizumi Tomoharu Yugawa Kyohei Kosai-Fujimoto Yukiko Inokuchi Shoichi Motomura Takashi Mano Yohei Toshima Takeo Itoh Shinji Harada Noboru Ikegami Toru Soejima Yuji Taketomi Akinobu Mori Masaki 《Surgery today》2020,50(4):379-388
Surgery Today - Inflammatory biomarkers such as the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) are reportedly predictive of the... 相似文献
33.
34.
35.
36.
Sachiyo Yoshio Tomonari Shimagaki Ryuki Hashida Takumi Kawaguchi Yuriko Tsutsui Yuzuru Sakamoto Yuichi Yoshida Hironari Kawai Shiori Yoshikawa Taiji Yamazoe Taizo Mori Yosuke Osawa Shinji Itoh Moto Fukai Tomoharu Yoshizumi Akinobu Taketomi Masaki Mori Tatsuya Kanto 《Hepatology research》2021,51(7):803-812
37.
Akinobu Nakamura MD Kazuno Omori MD Yasuo Terauchi MD 《Diabetes, obesity & metabolism》2021,23(10):2199-2206
Glucokinase, which phosphorylates glucose to form glucose-6-phosphate, plays a critical role in regulating blood glucose levels. On the basis of data of glucokinase-knockout and transgenic mice and humans with glucokinase mutations, glucokinase was targeted for drug development aiming to augment its activity, and thereby reduce hyperglycaemia in patients with diabetes. In fact, various small molecule compounds have been developed and clinically tested as glucokinase activators. However, some have been discontinued because of efficacy and safety issues. One of these issues is loss of the drug's efficacy over time. This unsustained glycaemic efficacy may be associated with the excess glycolysis by glucokinase activation in pancreatic beta cells, resulting in beta-cell failure. Recently, we have shown that glucokinase haploinsufficiency ameliorated glucose intolerance by increasing beta-cell function and mass in a mouse model of diabetes. Given that a similar phenotype has been observed in glucokinase-activated beta cells and diabetic beta cells, glucokinase inactivation may be a new therapeutic target for type 2 diabetes. 相似文献
38.
39.
Nishida T Kobashi H Fujioka S Fujio K Takaguchi K Ikeda H Kawaguchi M Ando M Araki Y Higashi T Shoji B Takaki A Iwasaki Y Sakaguchi K Shiratori Y Yamamoto K 《Journal of gastroenterology and hepatology》2008,23(5):794-803
Background and Aims: A prospective , non‐randomized cohort study on long‐term lamivudine treatment , comparing efficacy, drug resistance, and prognosis for various stages of chronic hepatitis B virus (HBV)–related liver disease was performed to elucidate the significance and indication of lamivudine for individual patients at each stage of disease. Methods: A total of 158 cases consisting of 87 chronic hepatitis, 28 compensated cirrhosis, and 43 decompensated cirrhosis, with serum HBV‐DNA > 5 log10 copies/mL and with elevated alanine aminotransferase (ALT) over twice the upper normal limit or complications of hepatic insufficiency, were administered 100 mg of lamivudine daily and monitored for HBV markers, biochemistry, and prognosis. Results: Lamivudine reduced HBV‐DNA and ALT equally in all groups. Serum albumin, prothrombin time (%), and platelet count increased in all groups. The increased margin of albumin was the highest in the decompensated cirrhosis and higher in the compensated cirrhosis than the chronic hepatitis groups. Cumulative incidence of virologic breakthrough was 16%, 42%, 49%, and 53% at 12, 24, 36, and 48 months, respectively, and the strongest predictive factor for lamivudine resistance was persistent HBV‐DNA at 3 months. Ascites, encephalopathy, and jaundice improved in the majority of patients with decompensated cirrhosis. On the other hand, hepatic failure developed or deteriorated in 10 patients after virologic breakthrough, and nine of them had decompensated cirrhosis. Conclusions: Lamivudine was effective in reducing HBV‐DNA and improving hepatic reserve at all stages and was most beneficial and significant for decompensated cirrhosis. Meanwhile, close monitoring of viral load and immediate rescue treatment for lamivudine resistance is necessary to prevent hepatic failure in decompensated cirrhosis. 相似文献
40.
Takeshi Fujita Akinobu Kakigi Natsumi Uehara Jun Yokoi Makiko Hara Hirotaka Shinomiya Masanori Teshima Ken-ichi Nibu 《Auris, nasus, larynx》2021,48(5):830-833
ObjectiveTo present our results of the external auditory canal (EAC) reconstruction procedure using rolled-up full-thickness skin graft with tympanoplasty after lateral temporal bone resection (LTBR) for early-stage EAC carcinoma.Patients and MethodsA retrospective review of 15 patients who had undergone LTBR with reconstruction of the EAC for T1 and T2 EAC cancer between 2016 and 2020.ResultsPostoperative mean air-bone gap was 30.7 decibel hearing level. Although a few patients experienced chronic granulation, persistent otorrhea, and/or laterization of the tympanic membrane, most patients showed no serious complications related to the EAC reconstruction.ConclusionEAC reconstruction using a full-thickness skin graft in combination with tympanoplasty is useful for minimizing the hearing loss, maintaining the cosmetic appearance, and facilitating the observation into the ear cavity. 相似文献